Work

A phase II trial of naxitamab plus stepped‐up dosing of GM ‐ CSF for patients with high‐risk neuroblastoma in second or later complete remission

Year: 2026

Type: article

Study design: Clinical Trial

Source: International Journal of Cancer

DOI: 10.1002/ijc.70374

Authors: Brian H. Kushner, Shakeel Modak, Charlie White, Ellen M. Basu, Stephen S. Roberts, Audrey Mauguen, Nai‐Kong V. Cheung

Institutions: Memorial Sloan Kettering Cancer Center, Oregon Health & Science University, OHSU Knight Cancer Institute

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Cancer Institute, Robert K Steel Family Foundation

Award: Cancer Center Support Grant

OpenAlex ID: W7128586185

FWCI: 4.197

Cites: 43

Cited by: 1

Related to: 10